Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
出版年份 2022 全文链接
标题
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
作者
关键词
-
出版物
Microbiology Spectrum
Volume 10, Issue 1, Pages -
出版商
American Society for Microbiology
发表日期
2022-01-05
DOI
10.1128/spectrum.01504-21
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cyclosporine: hope for severe COVID-19?
- (2021) Yashdeep Singh Pathania BMJ Supportive & Palliative Care
- Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine
- (2021) Kartikay Prasad et al. ACS Chemical Neuroscience
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Inhibition of SARS‐CoV‐2 replication using calcineurin inhibitors: are concentrations required clinically achievable?
- (2021) X. Solanich et al. JOURNAL OF INTERNAL MEDICINE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- Secreted Extracellular Cyclophilin A is a Novel Mediator of Ventilator Induced Lung Injury
- (2021) Marissa W. Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
- (2021) Mark Dittmar et al. Cell Reports
- Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
- (2021) Roberto Caricchio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
- (2021) Claudio Fenizia et al. Cells
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treating Covid-19 at the Inflection Point
- (2020) W. Winn Chatham et al. JOURNAL OF RHEUMATOLOGY
- Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern.
- (2020) Lidia Rudnicka et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
- (2020) Michelle Willicombe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
- (2020) Erkan Cure et al. RHEUMATOLOGY INTERNATIONAL
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Cyclosporine and COVID‐19: Risk or Favorable?
- (2020) Nadia Nicholine Poulsen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Calcineurin inhibitors revisited: A new paradigm for COVID-19?
- (2020) René Hage et al. Brazilian Journal of Infectious Diseases
- SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
- (2020) He-wei Jiang et al. Cellular & Molecular Immunology
- COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir
- (2020) Jean-Michel Pawlotsky CLINICAL INFECTIOUS DISEASES
- Cyclosporine: an old weapon in the fight against Coronaviruses
- (2020) Adam Molyvdas et al. EUROPEAN RESPIRATORY JOURNAL
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19
- (2020) Marla J Keller et al. Journal of Hospital Medicine
- Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts
- (2020) Jin Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The cytokine storm and COVID‐19
- (2020) Biying Hu et al. JOURNAL OF MEDICAL VIROLOGY
- Using cyclosporine in the COVID era: An emergent need for caution
- (2020) Ananta Khurana et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- SARS‐CoV2 and immunosuppression: A double‐edged sword
- (2020) Quirino Lai et al. Transplant Infectious Disease
- Immunological and inflammatory profiles in mild and severe cases of COVID-19
- (2020) Jin-Wen Song et al. Nature Communications
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- Interplay between SARS-CoV-2 and the type I interferon response
- (2020) Margarida Sa Ribero et al. PLoS Pathogens
- The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections
- (2020) Paulina Glowacka et al. Biology-Basel
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Analysis of SARS-CoV-2 vertical transmission during pregnancy
- (2020) Claudio Fenizia et al. Nature Communications
- Direct stimulation of ERBB2 highlights a novel cytostatic signaling pathway driven by the receptor Thr701 phosphorylation
- (2020) Marco Gaviraghi et al. Scientific Reports
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Cytokine profile and disease severity in patients with COVID-19
- (2020) Ali Ghazavi et al. CYTOKINE
- Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19
- (2020) Nicholas Parkinson et al. Scientific Reports
- Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
- (2020) Olga Sanchez-Pernaute et al. Reumatologia Clinica
- Modulation of innate immunity by cyclosporine A
- (2019) Alex M. Liddicoat et al. BIOCHEMICAL PHARMACOLOGY
- Cyclophilins and cyclophilin inhibitors in nidovirus replication
- (2018) Adriaan H. de Wilde et al. VIROLOGY
- Interleukin 1α and the inflammatory process
- (2016) Nelson C Di Paolo et al. NATURE IMMUNOLOGY
- Cyclophilin B enhances HIV-1 infection
- (2016) Jason DeBoer et al. VIROLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- TNF-α signalling and inflammation: interactions between old acquaintances
- (2013) Hana Zelová et al. INFLAMMATION RESEARCH
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Cyclophilin A and viral infections
- (2012) Daijun Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis
- (2011) A. Narla et al. BLOOD
- Cyclosporin A inhibits the replication of diverse coronaviruses
- (2011) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Human Coronavirus-Induced Neuronal Programmed Cell Death Is Cyclophilin D Dependent and Potentially Caspase Dispensable
- (2011) D. J. Favreau et al. JOURNAL OF VIROLOGY
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- (2011) Susanne Pfefferle et al. PLoS Pathogens
- A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
- (2010) Nicolas Manel et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started